SC 13G

Company

COSCIENS Biopharma Inc.

Filed

April 26, 2010

Accession Number

0000950123-10-038305

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →